Treatment of methamphetamine use disorders: an update
- PMID: 12220612
- DOI: 10.1016/s0740-5472(02)00256-8
Treatment of methamphetamine use disorders: an update
Abstract
Methamphetamine (MA) is a major public health and criminal justice problem in much of the Western and Midwestern US, and its use seems to be increasing east of the Mississippi River. MA use can produce significant psychiatric and medical consequences, including psychosis, dependence, overdose, and death. Cognitive behavioral therapy and contingency management are among the most promising approaches for treatment of MA abuse and dependence. A multisite study evaluating the Matrix Model of outpatient treatment will soon be completed to provide data on this manualized approach. An ambitious program of pharmacotherapy development research is currently being sponsored by the National Institute on Drug Abuse (NIDA) in geographic areas significantly affected by MA use. The development of treatments for MA-related problems is particularly critical for a number of user groups including MA users who experience persistent psychosis, pregnant women and women with children, gay and bisexual men, and MA users involved in the criminal justice system.
Copyright 2002 Elsevier Science Inc.
Similar articles
-
Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence.Curr Drug Abuse Rev. 2010 Dec;3(4):222-38. doi: 10.2174/1874473711003040222. Curr Drug Abuse Rev. 2010. PMID: 21208168 Review.
-
Methamphetamine abuse.Am Fam Physician. 2007 Oct 15;76(8):1169-74. Am Fam Physician. 2007. PMID: 17990840 Review.
-
Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.Drug Alcohol Depend. 2005 May 9;78(2):125-34. doi: 10.1016/j.drugalcdep.2004.10.004. Epub 2004 Nov 28. Drug Alcohol Depend. 2005. PMID: 15845315 Clinical Trial.
-
A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.Addiction. 2004 Jun;99(6):708-17. doi: 10.1111/j.1360-0443.2004.00707.x. Addiction. 2004. PMID: 15139869 Clinical Trial.
-
Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.J Psychoactive Drugs. 2003 May;35 Suppl 1:161-8. doi: 10.1080/02791072.2003.10400511. J Psychoactive Drugs. 2003. PMID: 12825759
Cited by
-
Methamphetamine-associated psychosis.J Neuroimmune Pharmacol. 2012 Mar;7(1):113-39. doi: 10.1007/s11481-011-9288-1. Epub 2011 Jul 5. J Neuroimmune Pharmacol. 2012. PMID: 21728034 Free PMC article. Review.
-
Glial cell modulators attenuate methamphetamine self-administration in the rat.Eur J Pharmacol. 2013 Feb 15;701(1-3):124-30. doi: 10.1016/j.ejphar.2013.01.016. Epub 2013 Jan 31. Eur J Pharmacol. 2013. PMID: 23375937 Free PMC article.
-
A Qualitative Study of the Relationship Between Methamphetamine Abuse and Sexual Dysfunction in Male Substance Abusers.Int J High Risk Behav Addict. 2016 Jun 13;5(3):e29640. doi: 10.5812/ijhrba.29640. eCollection 2016 Sep. Int J High Risk Behav Addict. 2016. PMID: 27803891 Free PMC article.
-
Oxytocin and Rodent Models of Addiction.Int Rev Neurobiol. 2018;140:201-247. doi: 10.1016/bs.irn.2018.07.007. Epub 2018 Aug 14. Int Rev Neurobiol. 2018. PMID: 30193705 Free PMC article. Review.
-
Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States.JAMA Netw Open. 2018 Oct 5;1(6):e183758. doi: 10.1001/jamanetworkopen.2018.3758. JAMA Netw Open. 2018. PMID: 30646256 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical